Chronic lymphocytic leukemia |
Peripheral blood |
Down |
IKK BETA |
NF-Kappa B signaling pathway |
miR-708 regulates the NF-Kappa B signaling pathway by targeting IKK beta (inhibitor of kappa light polypeptide gene enhancer in B cell) in chronic lymphocytic leukemia. |
Baer et al., 2015 |
Parkinson's disease |
SH-SY5Y |
Up |
KEAP1 |
Nrf2 signaling pathway |
MicroRNA-7 is upregulated in the brain, suppresses the expression of Keap1 in human neuroblastoma cells. Subsequently, this event activates Nrf2 pathway. |
Kabaria et al., 2015 |
Parkinson's disease |
SH-SY5Y |
Up |
REL A |
Glycolysis pathway |
MicroRNA-7 increases Glut3 expression, promotes glycolysis, and subsequently inhibits MPP(+)-induced cell death by targeting RelA. |
Chaudhuri et al., 2015 |
Parkinson's disease |
HEK293 |
Up |
ALPHA SYNUCLEIN |
mTOR pathway |
MicroRNA-7 protects neurons from cell death by interfering with the MPP+-induced suppression of mTOR signaling pathway. |
Fragkouli et al., 2014 |
Multiple sclerosis |
COS-7 |
Up |
SMAD4 |
TGF-beta signaling pathway |
Upregulation of miR-708 inhibits the expression of SMAD4. MicroRNA-708 negatively regulates TGF-beta signaling, and dampens the development of regulatory T cell, thereby increasing susceptibility to developing multiple sclerosis. |
Severin et al., 2016 |
Cervical cancer |
HeLa, C-4-1, Ca Ski, SiHa |
Up |
BCL 2 |
Apoptosis pathway |
MicroRNA-744 suppresses the expression of Bcl-2, which leads to the inactivation of apoptosis signaling and the cell proliferation of cervical cancer cells, ameliorating cervical cancer growth and progression. |
Chen et al., 2016 |
Laryngeal squamous cell carcinoma |
Lung |
Up |
PDCD4 |
NF-Kappa B signaling pathway |
Down-regulation of miR-744 is associated with suppression of laryngeal squamous cell carcinoma metastasis by inactivating NF-Kappa B signaling pathway. |
Li et al., 2016 |
Laryngeal squamous cell carcinoma |
Lung |
Up |
PTEN |
mTOR pathway |
Down-regulation of miR-744 is associated with suppression of laryngeal squamous cell carcinoma metastasis by inactivating AKT/mTOR signaling pathway. |
Li et al., 2016 |
Metastatic lung cancer |
Lung |
Down |
P21 |
PI3K-Akt signaling pathway |
Upregulation of the miRNA-708 inhibits cell survival and metastasis through its direct target p21, and suppresses the PI3K-Akt signaling pathway and stem cell-like characteristics of lung cancer cells. |
Wu et al., 2016 |
Non-small cell lung cancer |
Lung |
|
SMARCD1 |
Apoptosis pathway |
MicroRNA-7 suppresses p53-dependent apoptosis-related gene BAX (BCL2-associated X protein) and expression of p21 by interfering with the interaction between SMARCD1 and p53, thereby decreasing caspase3 cleavage and the downstream apoptosis cascades. |
Hong et al., 2016 |
Triple negative breast cancer |
MDA-MB-231 |
|
RAF 1 |
Raf signaling pathway |
Decreased expression of miR-7 by lapatinib is associated with the activation of Raf-1 signaling pathway in triple-negative breast cancer. |
Hsiao et al., 2015 |
Prostate cancer |
PC-3 |
Down |
KLF4 |
PI3K-Akt signaling pathway |
MicroRNA-7 suppresses the stemness of prostate cancer stem-like cells and tumorigenesis through inhibiting KLF4/PI3K/Akt/p21 pathway. |
Chang et al., 2015 |
Ovarian cancer |
Ovary |
Down |
EGFR |
PI3K-Akt signaling pathway |
MicroRNA-7 suppresses tumor metastasis via PI3K-Akt signaling pathway inactivation by inhibiting EGFR expression in epithelial ovarian cancer. |
Zhou et al., 2014 |
Ovarian cancer |
Ovary |
Down |
EGFR |
ERK pathway |
MicroRNA-7 suppresses tumor metastasis via ERK1/2 pathway inactivation by inhibiting EGFR expression in epithelial ovarian cancer. |
Zhou et al., 2014 |
Pancreatic carcinoma |
PANC-1, BxPC-3, CFPAC-1, Capan-1 |
Up |
SFRP1 |
Wnt signaling pathway |
MicroRNA-744 promotes tumorigenicity in pancreatic cancer by directly targeting secreted frizzled-related protein 1 (SFRP1), important negative regulator of Wnt signaling pathway. |
Zhou et al., 2015 |
Pancreatic carcinoma |
PANC-1, BxPC-3, CFPAC-1, Capan-1 |
Up |
GSK 3 BETA |
Wnt signaling pathway |
MicroRNA-744 promotes tumorigenicity in pancreatic cancer by directly targeting glycogen synthase kinase 3-beta (GSK3-beta), important negative regulator of Wnt signaling pathway. |
Zhou et al., 2015 |
Pancreatic carcinoma |
PANC-1, BxPC-3, CFPAC-1, Capan-1 |
Up |
TLE3 |
Wnt signaling pathway |
MicroRNA-744 promotes tumorigenicity in pancreatic cancer by directly targeting transducin-like enhancer of split 3 (TLE3), important negative regulator of Wnt signaling pathway. |
Zhou et al., 2015 |